Commercialization Is Outpacing Care, and Everyone Knows It
Silent • January 21, 2026

Tone at the Top | For clinicians, regulators, and practitioners



There is an uncomfortable truth circulating quietly through conference halls, investor decks, clinics, and regulatory briefings alike: the psychedelic field is moving faster than the human systems that support it. Everyone feels it. Few are naming it plainly.


This is not an argument against growth. Nor is it nostalgia for a pre-commercial past that never truly existed. Psychedelic substances have always lived at the intersection of healing, power, culture, and economy. What has changed is the velocity and the incentives driving it.


Today’s growth curve rewards speed, branding, and market capture far more than clinical depth, ethical maturity, or long-term integration. That imbalance is no longer theoretical. It is structural. And it is beginning to show.


Venture Timelines vs. Human Integration Timelines

Capital moves on quarters. Humans do not.


Venture-backed timelines demand proof points: indications approved, clinics opened, patient throughput increased, IP secured. These pressures shape everything downstream, from trial design to therapist training to how outcomes are defined.

But psychedelic care unfolds on a different clock. Integration is nonlinear. Adverse experiences may surface months later. Meaning-making does not obey revenue models. A treatment that “works” at week six may unravel at month six if the container is thin.


Clinicians see this tension daily. Practitioners feel it in their bodies. Regulators sense it in the growing gap between protocol compliance and lived reality. When financial timelines compress human processes, the risk is not inefficiency; it is harm that arrives quietly, after the dashboards are green.


Brand Narratives Masking Structural Weakness

In a crowded market, story becomes currency.


Words like healing, transformation, and revolution now appear more frequently in pitch decks than in clinical supervision. The aesthetic of care, soft lighting, indigenous symbolism, carefully curated language, can give the impression of depth without the burden of building it.


Brand narratives can temporarily substitute for infrastructure. They can smooth over under-trained facilitators, thin integration pathways, or governance models that treat ethics as an appendix rather than a spine.


This is not cynicism; it is pattern recognition. When narrative runs ahead of operational maturity, organizations borrow trust instead of earning it. Borrowed trust always comes due.


The Monetization of Mystique

Psychedelics carry something rare in modern medicine: mystery.

That mystery is not a flaw, it is part of their power. But mystery, once monetized, becomes fragile. The field now sells access not only to molecules, but to meaning itself. Retreats promise insight. Clinics promise rebirth. Platforms promise scalability of the ineffable.


When mystique becomes a revenue driver, two distortions emerge. First, expectations inflate beyond what any ethical clinician would guarantee. Second, adverse outcomes are reframed as user failure rather than system responsibility.


This dynamic quietly erodes informed consent. Patients are no longer entering treatment; they are entering a narrative they feel pressured to fulfill.


What Happens When Trust Collapses

Trust is the invisible substrate of this entire ecosystem.

Patients extend trust not just to clinicians, but to institutions, regulators, and the unspoken promise that someone has thought deeply about second- and third-order effects. When trust collapses, it does not do so symmetrically.


Patients withdraw first. Then clinicians disengage. Regulators respond last, but decisively. History offers no shortage of examples where promising therapeutic modalities were set back decades, not because they failed clinically, but because they failed ethically under pressure.


A single high-profile breach, poor screening, inadequate integration, conflicts of interest obscured by branding, can reset the entire regulatory climate. Trust, once broken, is not rebuilt by marketing. It is rebuilt by restraint.


The Leadership Question No One Can Avoid

This is not a frontline problem. It is a leadership problem.

Boards, executives, principal investigators, and policy architects are shaping incentive structures right now that will determine whether this field matures, or fractures. The question is not can we grow? The question is what kind of growth are we legitimizing?

True leadership in this space requires resisting false binaries. It is possible to be commercially viable and clinically rigorous. It is possible to scale and still protect the slow, human work of integration. But it requires governance models that value delay as much as delivery.


It requires metrics that track downstream well-being, not just upstream access. It requires saying “not yet” when the market is shouting “now.”


Call to Action: Slow Growth Is Not Failure

Let us be precise.


  • Slow growth is not failure.
  • Careful sequencing is not weakness.
  • Ethical friction is not inefficiency.
  • Unexamined growth, however, is a liability.


For clinicians: protect your boundaries even when demand surges.
For practitioners: name when the container is thinning.


For regulators: resist pressure to equate speed with progress.
For leaders: build systems worthy of the states you are unleashing.

This field does not need more momentum. It needs more maturity.


The real question is not whether psychedelics will change medicine. They already have. The question is whether the industry built around them will earn the right to last.


ABOUT THE AUTHOR


Silent


Silent provides the tools for seekers to recognize their path and enables self-reliance for spiritual and magickal growth. 


Seekers gain insight from his work and find their inner calm from his ability to listen and help others reflect.

By Silent • October 18, 2026
A psilocybin drug is nearing FDA review, and the people building it say they do not yet know how much of the healing comes from the experience itself.
By Silent • October 4, 2026
Four weeks before Samhain, a recent study of grief technology and a 4,000-year-old household ritual ask the same question: where does love go when its person has died?
By Silent • September 26, 2026
A new study of American religious life shows belief eroding even inside the tradition best known for keeping its people — and asks what's actually left once certainty goes. On September 22nd, Pew Research Center published one of the more quietly startling religion studies of the year, and it isn't about a fringe group or a sect nobody expected to hold together. It's about the Church of Jesus Christ of Latter-day Saints — a faith practically famous for how thoroughly it keeps its own. In 2007, seven in ten Americans raised Mormon still identified as Mormon in adulthood. By 2023–24, that number had fallen to fifty-four percent. Nearly a third of those raised in the faith now describe themselves as atheist, agnostic, or "nothing in particular" — double the share sixteen years earlier. Even among those who stayed, certainty thinned: belief in God "without doubt" dropped from ninety percent to seventy-six, daily prayer from eighty-two to seventy-three. I want to handle this data carefully. It's easy to hear "church retention falls" as bad news for the faithful, or quiet vindication for everyone else. Both readings miss the point. LDS retention, even diminished, still outperforms most American denominations. This isn't a story about one institution losing its grip. It's a story about certainty tested under close to the best conditions available to it — strong community, generational continuity, real doctrinal coherence — and still, gradually, coming apart at the seams. If it can happen there, the architecture holding up anyone's inherited certainty is less permanent than it looks from inside it. What the Study Can't Measure Pew can count who still checks a box on a survey. It can't tell you what it's like to be the one doing the leaving — or the one staying while something you used to feel without effort quietly stops being available to you. That's a different kind of data, and it's the kind spiritual direction actually works with. I've sat across from people in exactly that middle distance: still going through the motions, still loving their community, privately unsure whether anyone is listening. It's one of the loneliest positions a person can occupy, because it often can't be spoken aloud inside the very community that would otherwise hold you. You're not ready to call yourself a leaver. You can't quite call yourself a believer without qualifying it into something smaller. Most traditions have no name for that middle room, so people sit in it alone, assuming they're the only one there. They rarely are. The Pew numbers say so. The Gate You Can't Skip There's an old Sumerian story about Inanna, Queen of Heaven, who descends into the underworld to see her sister Ereshkigal. At each of seven gates, the gatekeeper takes something from her — her crown, her jewelry, her royal robes — until she arrives at the bottom stripped of every marker that told anyone, including herself, who she was. Only then does she meet what's actually down there. The myth doesn't treat this as tragedy. It treats it as the price of admission to a truth the ornaments were never built to survive. Deconstruction, in the modern sense, usually doesn't announce itself as myth. It shows up as a nagging doubt during a hymn, a question you stop asking out loud, a certainty that used to arrive automatically and now has to be manufactured. But it follows the same shape as Inanna's descent: something is removed at every threshold, and there's no route past the gate that lets you keep all your jewelry. The theology goes first, sometimes. Then the community. Then, for some, the habit of feeling addressed by anything larger than themselves. I'm not going to rush in here and repair anyone's faith, and I'd be suspicious of anything that claimed it could. Some absences aren't problems waiting on a solution. The silence where God used to answer immediately isn't necessarily a malfunction — it may be the actual terrain, and the task is learning to stand in it rather than paper over it with a faster answer. The Question Worth Sitting With So here's what I'd actually ask, if you were sitting across from me instead of reading this: if the certainty you were handed finished eroding completely — not into a different, tidier belief, not into an argument you could win, but into open silence — could you survive being someone who simply doesn't know? Not forever. Just for now, while it's true. I won't answer that for you. I don't think it can be answered from outside the room it happens in. A Practice for the Middle Room If you recognize yourself here — still present, quietly uncertain — try this before the week is out. Write one sentence naming exactly what you used to believe without effort. Then write, honestly, whether that sentence is still true for you, true with an asterisk, or no longer true at all. Don't fix it. Don't defend it to an imagined critic. Just let it sit there, accurate, on the page. That's the whole practice. It won't resolve anything tonight. It will at least stop costing you the extra work of pretending, even to yourself, that nothing has moved. Closing Reflection Nearly a third of a generation raised inside one of America's most cohesive faiths now names no faith at all. Whatever tradition raised you, ask honestly: which of your certainties are still yours, and which have you simply kept saying out of habit? Sit with the answer before you try to fix it.
Show More